BBCNEWS Click June 4, 2024 01:53:00
After the als looked at the data? exactly. so here, for example, i can see that the ai risk is low. its a low—risk patient. some cancer experts see real promise in al tools like 0wkin�*s, but there are still challenges. its really exciting - work and its showing where the future i lies for pathology. while it might not be absolutely there yetl for clinical deployment, - i think its a really important first step and something that we should be encouraged by. the real benefit to patients of th...
Source: archive.org